Stock Events

Stock Events

Novartis 

$144
2212
+$0+0% Tuesday 16:32

Statistics

Day High
144
Day Low
144
52W High
172.01
52W Low
106.5
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
21.02
Dividend Yield
3.29%
Dividend
4.73

Upcoming

11
MAR 27
Dividend Ex
Estimated
 
12
MAR 27
Dividend Payment
Estimated
 
13
MAR 28
Dividend Ex
Estimated
 
14
MAR 28
Dividend Payment
Estimated
 

Dividends

3.29%Dividend Yield
Mar 26
$4.73
Mar 25
$3.97
Mar 24
$3.76
Mar 23
$3.43
Mar 22
$3.33
10Y Growth
5.64%
5Y Growth
7.95%
3Y Growth
11.32%
1Y Growth
19.23%

Earnings

21JulExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
1.8
2.01
2.21
2.42
Expected EPS
2.178273
Actual EPS
N/A

Financials

24.67%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
113.35BRevenue
27.97BNet Income

Analyst Ratings

170Average Price Target
The highest estimate is 170.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
67%
Hold
33%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NVSEF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap149.77B
Pfizer competes directly with Novartis in various therapeutic areas, including cardiovascular, oncology, and immunology.
Johnson & Johnson
JNJ
Mkt Cap546.9B
Johnson & Johnson, through its pharmaceutical segment, competes in areas such as immunology and oncology, similar to Novartis.
Merck
MRK
Mkt Cap277.02B
Merck is a key competitor in the oncology sector, directly competing with Novartis' cancer treatments.
Roche
RHHBY
Mkt Cap328.49B
Roche competes closely with Novartis, especially in oncology and ophthalmology, with both companies headquartered in Switzerland.
Abbvie
ABBV
Mkt Cap365.43B
AbbVie competes in the immunology and oncology markets, areas where Novartis has significant investments.
GSK
GSK
Mkt Cap103.01B
GlaxoSmithKline competes with Novartis in respiratory, vaccines, and HIV, areas where Novartis has presence or interest.
Bristol-Myers Squibb
BMY
Mkt Cap118.87B
Bristol Myers Squibb is a competitor in the oncology and cardiovascular markets, directly competing with Novartis' drug portfolio.
Sanofi
SNY
Mkt Cap110.4B
Sanofi competes with Novartis in areas such as vaccines, oncology, and cardiovascular diseases.
Astrazeneca
AZN
Mkt Cap286.4B
AstraZeneca competes in the oncology, cardiovascular, and respiratory sectors, overlapping with Novartis' interests.
AMGEN
AMGN
Mkt Cap178B
Amgen competes with Novartis in the biopharmaceutical sector, particularly in treatments for bone diseases, cancer, and cardiovascular diseases.

About

There is no Profile data available for NOT.SG.
Show more...
CEO
Dr. Vasant Narasimhan M.D.
Employees
75883
Country
Switzerland
ISIN
CH0012005267

Listings

MI
IT
1NOVN.MI
F
DE
NOT1.F
MX
MX
NVSN.MX
XETRA
DE
NOT.XETRA

0 Comments

Share your thoughts

FAQ

What is Novartis stock price today?▼
The current price of NVSEF is $144 USD — it has increased by +0% in the past 24 hours. Watch Novartis stock price performance more closely on the chart.
What is Novartis stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Novartis stocks are traded under the ticker NVSEF.
Is Novartis stock price growing?▼
NVSEF stock has fallen by -0.69% compared to the previous week, the month change is a -7.02% fall, over the last year Novartis has showed a +29.73% increase.
When is the next Novartis earnings date?▼
Novartis is going to release the next earnings report on July 21, 2026.
What were Novartis earnings last quarter?▼
NVSEF earnings for the last quarter are 1.99 USD per share, whereas the estimation was 2.1 USD resulting in a -5.43% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Novartis revenue for the last year?▼
Novartis revenue for the last year amounts to 113.35B USD.
What is Novartis net income for the last year?▼
NVSEF net income for the last year is 27.97B USD.
Does Novartis pay dividends?▼
Yes, NVSEF dividends are paid annual. The last dividend per share was 4.73 USD. As of today, Dividend Yield (FWD)% is 3.29%.
How many employees does Novartis have?▼
As of May 06, 2026, the company has 75,883 employees.
In which sector is Novartis located?▼
Novartis operates in the Health & Wellness sector.
When did Novartis complete a stock split?▼
Novartis has not had any recent stock splits.
Where is Novartis headquartered?▼
Novartis is headquartered in Basel, Switzerland.